Gan & Lee Pharmaceuticals. (SHA:603087)
China
· Delayed Price · Currency is CNY 63.60
+1.20 (1.92%)
At close: Dec 5, 2025
SHA:603087 Revenue
Gan & Lee Pharmaceuticals. had revenue of 980.24M CNY in the quarter ending September 30, 2025, with 5.39% growth. This brings the company's revenue in the last twelve months to 3.85B, up 30.54% year-over-year. In the year 2024, Gan & Lee Pharmaceuticals. had annual revenue of 3.05B with 16.77% growth.
Revenue (ttm)
3.85B
Revenue Growth
+30.54%
P/S Ratio
9.84
Revenue / Employee
733.53K
Employees
5,245
Market Cap
37.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 437.31M | 16.77% |
| Dec 31, 2023 | 2.61B | 895.77M | 52.31% |
| Dec 31, 2022 | 1.71B | -1.90B | -52.60% |
| Dec 31, 2021 | 3.61B | 250.16M | 7.44% |
| Dec 31, 2020 | 3.36B | 466.82M | 16.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |